-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceuticals.
com technical article] APIs, also known as active pharmaceutical ingredients, are substances produced by chemical synthesis, plant extraction or biotechnology that cannot be taken directly by patients, generally need to be added with excipients and processed before they can be made Medications used directly
.
At present, China has become one of the major API markets in the world
.
With the acceleration of China's medical policy reform in recent years, the number of new DMF registrations obtained in China every year has continued to rise, and the export scale of APIs has also begun to grow rapidly
.
Pharmaceutical equipment (Source: Pharmaceutical Network) According to data from the National Bureau of Statistics, in 2019, China's chemical drug technical output reached 2.
769 million tons, a year-on-year increase of 20.
2%; A year-on-year increase of 2.
7%
.
In addition, the "2020-2024 China API Industry In-depth Research and Investment Prospect Forecast Report" also shows that in 2019, China's API market has reached 257.
929 billion yuan, a year-on-year increase of 6.
4%
.
Industry analysts believe that in the medium and long term, as the production capacity of APIs gradually shifts to the Asia-Pacific region and the demand for APIs under centralized procurement increases, China's API market will continue to expand
.
However, under the background that there are still small and scattered chaos in the domestic API industry, and there are still problems such as low-price competition, serious waste of resources, and overcapacity among enterprises, the industry expects that the domestic API industry will experience a transition period and enter a new stage of development
.
At this next stage, the industry believes that the entire API industry will also put forward higher and more requirements for the standardized development and cost control capabilities of API companies
.
In fact, the production process of APIs is often accompanied by waste water, waste gas, waste residue and other by-products
.
In recent years, with the country's increasing emphasis on environmental protection, it has clearly put forward higher environmental protection requirements for the development of the API industry
.
For example, in 2018, the "Environmental Protection Tax Law" was officially implemented.
The introduction of environmental protection tax and the "look back" of environmental protection supervision further increased the pressure on API companies.
Nearly 70% of API manufacturers stopped production because they could not afford the high environmental protection investment
.
The introduction of the "Guiding Opinions on Promoting the Green Development of the API Industry" in 2019 accelerated the elimination of backward production capacity and promoted the integration of the industry
.
In this context, the industry believes that in the future, raw materials with environmental protection and green technology will be the key encouraged development direction of the national industry
.
Affected by this, the industry expects that the API pharmaceutical equipment industry will also usher in more development opportunities
.
In particular, low-cost, high-efficiency, energy-saving and environmentally friendly pharmaceutical equipment may lead to new trends in the production of APIs
.
It is understood that, in fact, many domestic API equipment companies have begun to make continuous efforts in the field of environmental protection and energy saving
.
For example
.
Manufacturers of drying equipment have continuously strengthened investment in research and development to create environmentally friendly and energy-saving API production equipment
.
The company has established a special environmental protection company and a supporting engineering experiment center, and also established the core elements of energy-saving, consumption-reducing and environmental-friendly product design to actively develop and produce green equipment.
At present, it has gradually achieved good economic and social benefits
.
There are also many companies that are integrating new technologies into the R&D and production of API equipment
.
For example, some companies have developed a liquid nitrogen freeze dryer that uses liquid nitrogen as a cold source to cool the system; under the action of the existing vacuum system, gaseous water can be transported into the freeze dryer pipeline for hydrogen peroxide A new type of sterilization process for sterilization and disinfection; a fully automatic solid-liquid separation solution that reduces energy consumption, water consumption, manpower requirements and waste water treatment costs, and improves product recovery
.
In addition, some companies have established an experienced technical team specializing in heat exchange equipment.
The products aim to save energy and reduce consumption, and are committed to providing customers with effective solutions to reduce costs and increase efficiency
.
In general, these new technologies, new equipment and new solutions of the current pharmaceutical equipment companies are further providing strong technological support for the high-quality production of API companies
.
As the API industry enters a boom cycle, the industry expects that the market for these related API equipment will also usher in growth
.
However, it is worth noting that opportunities often coexist with challenges
.
Therefore, while seizing the opportunity, API equipment enterprises also need to constantly adapt to the new demands and requirements of the market, innovate equipment and technology, and improve the equipment structure, in order to help the API industry of innovative medicines continue to develop with higher quality, and provide users with better services.
Provide more and better services
.
com technical article] APIs, also known as active pharmaceutical ingredients, are substances produced by chemical synthesis, plant extraction or biotechnology that cannot be taken directly by patients, generally need to be added with excipients and processed before they can be made Medications used directly
.
At present, China has become one of the major API markets in the world
.
With the acceleration of China's medical policy reform in recent years, the number of new DMF registrations obtained in China every year has continued to rise, and the export scale of APIs has also begun to grow rapidly
.
Pharmaceutical equipment (Source: Pharmaceutical Network) According to data from the National Bureau of Statistics, in 2019, China's chemical drug technical output reached 2.
769 million tons, a year-on-year increase of 20.
2%; A year-on-year increase of 2.
7%
.
In addition, the "2020-2024 China API Industry In-depth Research and Investment Prospect Forecast Report" also shows that in 2019, China's API market has reached 257.
929 billion yuan, a year-on-year increase of 6.
4%
.
Industry analysts believe that in the medium and long term, as the production capacity of APIs gradually shifts to the Asia-Pacific region and the demand for APIs under centralized procurement increases, China's API market will continue to expand
.
However, under the background that there are still small and scattered chaos in the domestic API industry, and there are still problems such as low-price competition, serious waste of resources, and overcapacity among enterprises, the industry expects that the domestic API industry will experience a transition period and enter a new stage of development
.
At this next stage, the industry believes that the entire API industry will also put forward higher and more requirements for the standardized development and cost control capabilities of API companies
.
In fact, the production process of APIs is often accompanied by waste water, waste gas, waste residue and other by-products
.
In recent years, with the country's increasing emphasis on environmental protection, it has clearly put forward higher environmental protection requirements for the development of the API industry
.
For example, in 2018, the "Environmental Protection Tax Law" was officially implemented.
The introduction of environmental protection tax and the "look back" of environmental protection supervision further increased the pressure on API companies.
Nearly 70% of API manufacturers stopped production because they could not afford the high environmental protection investment
.
The introduction of the "Guiding Opinions on Promoting the Green Development of the API Industry" in 2019 accelerated the elimination of backward production capacity and promoted the integration of the industry
.
In this context, the industry believes that in the future, raw materials with environmental protection and green technology will be the key encouraged development direction of the national industry
.
Affected by this, the industry expects that the API pharmaceutical equipment industry will also usher in more development opportunities
.
In particular, low-cost, high-efficiency, energy-saving and environmentally friendly pharmaceutical equipment may lead to new trends in the production of APIs
.
It is understood that, in fact, many domestic API equipment companies have begun to make continuous efforts in the field of environmental protection and energy saving
.
For example
.
Manufacturers of drying equipment have continuously strengthened investment in research and development to create environmentally friendly and energy-saving API production equipment
.
The company has established a special environmental protection company and a supporting engineering experiment center, and also established the core elements of energy-saving, consumption-reducing and environmental-friendly product design to actively develop and produce green equipment.
At present, it has gradually achieved good economic and social benefits
.
There are also many companies that are integrating new technologies into the R&D and production of API equipment
.
For example, some companies have developed a liquid nitrogen freeze dryer that uses liquid nitrogen as a cold source to cool the system; under the action of the existing vacuum system, gaseous water can be transported into the freeze dryer pipeline for hydrogen peroxide A new type of sterilization process for sterilization and disinfection; a fully automatic solid-liquid separation solution that reduces energy consumption, water consumption, manpower requirements and waste water treatment costs, and improves product recovery
.
In addition, some companies have established an experienced technical team specializing in heat exchange equipment.
The products aim to save energy and reduce consumption, and are committed to providing customers with effective solutions to reduce costs and increase efficiency
.
In general, these new technologies, new equipment and new solutions of the current pharmaceutical equipment companies are further providing strong technological support for the high-quality production of API companies
.
As the API industry enters a boom cycle, the industry expects that the market for these related API equipment will also usher in growth
.
However, it is worth noting that opportunities often coexist with challenges
.
Therefore, while seizing the opportunity, API equipment enterprises also need to constantly adapt to the new demands and requirements of the market, innovate equipment and technology, and improve the equipment structure, in order to help the API industry of innovative medicines continue to develop with higher quality, and provide users with better services.
Provide more and better services
.
